Kim KB - Search Results

1

Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab.

Eroglu Z, Kim DW, Wang X, Camacho LH, Chmielowski B, Seja E, Villanueva A, Ruchalski K, Glaspy JA, Kim KB, Hwu WJ, Ribas A. Eroglu Z, et al. Among authors: kim dw, kim kb. Eur J Cancer. 2015 Nov;51(17):2689-97. doi: 10.1016/j.ejca.2015.08.012. Epub 2015 Sep 10. Eur J Cancer. 2015. PMID: 26364516 Free PMC article.

2

Biochemotherapy in patients with metastatic anorectal mucosal melanoma.

Kim KB, Sanguino AM, Hodges C, Papadopoulos NE, Eton O, Camacho LH, Broemeling LD, Johnson MM, Ballo MT, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Prieto VG, Bedikian AY. Kim KB, et al. Cancer. 2004 Apr 1;100(7):1478-83. doi: 10.1002/cncr.20113. Cancer. 2004. PMID: 15042682 Free article.

3

Pilot study of high-dose, concurrent biochemotherapy for advanced melanoma.

Kim KB, Eton O, East MJ, Hodges C, Papadopoulos NE, Grimm EA, Bedikian AY. Kim KB, et al. Cancer. 2004 Aug 1;101(3):596-603. doi: 10.1002/cncr.20403. Cancer. 2004. PMID: 15274073 Free article.

4

A critical assessment of adjuvant radiotherapy for inguinal lymph node metastases from melanoma.

Ballo MT, Zagars GK, Gershenwald JE, Lee JE, Mansfield PF, Kim KB, Camacho LH, Hwu P, Ross MI. Ballo MT, et al. Among authors: kim kb. Ann Surg Oncol. 2004 Dec;11(12):1079-84. doi: 10.1245/ASO.2004.12.039. Ann Surg Oncol. 2004. PMID: 15576833

5

A phase II trial of arsenic trioxide in patients with metastatic melanoma.

Kim KB, Bedikian AY, Camacho LH, Papadopoulos NE, McCullough C. Kim KB, et al. Cancer. 2005 Oct 15;104(8):1687-92. doi: 10.1002/cncr.21386. Cancer. 2005. PMID: 16130126 Free article. Clinical Trial.

6

Prospective assessment of the reliability, validity, and sensitivity to change of the Functional Assessment of Cancer Therapy-Melanoma questionnaire.

Cormier JN, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Camacho LH, Kim K, Webster K, Cella D, Palmer JL. Cormier JN, et al. Cancer. 2008 May 15;112(10):2249-57. doi: 10.1002/cncr.23424. Cancer. 2008. PMID: 18383513 Free article.

7

Systemic therapy for unresectable metastatic melanoma: impact of biochemotherapy on long-term survival.

Bedikian AY, Johnson MM, Warneke CL, McIntyre S, Papadopoulos N, Hwu WJ, Kim K, Hwu P. Bedikian AY, et al. J Immunotoxicol. 2008 Apr;5(2):201-7. doi: 10.1080/15476910802131519. J Immunotoxicol. 2008. PMID: 18569391 Free article.

8

Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma.

Bedikian AY, Johnson MM, Warneke CL, Papadopoulos NE, Kim K, Hwu WJ, McIntyre S, Hwu P. Bedikian AY, et al. Cancer Invest. 2008 Jul;26(6):624-33. doi: 10.1080/07357900802027073. Cancer Invest. 2008. PMID: 18584354

9

Phase II trial of imatinib mesylate in patients with metastatic melanoma.

Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Kim KB, et al. Br J Cancer. 2008 Sep 2;99(5):734-40. doi: 10.1038/sj.bjc.6604482. Epub 2008 Aug 19. Br J Cancer. 2008. PMID: 18728664 Free PMC article. Clinical Trial.

10

Phase I study of the combination of docetaxel, temozolomide and cisplatin in patients with metastatic melanoma.

Kim KB, Hwu WJ, Papadopoulos NE, Bedikian AY, Camacho LH, Ng C, Hernandez IM, Frost AM, Jack MA, Hwu P. Kim KB, et al. Cancer Chemother Pharmacol. 2009 Jun;64(1):161-7. doi: 10.1007/s00280-008-0861-0. Epub 2008 Nov 11. Cancer Chemother Pharmacol. 2009. PMID: 19002462 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,353 results

Search Page

Filters